41
|
|
|
Chromosome 17 open reading frame 107 |
- |
|
42
|
|
|
Chromosome 17 open reading frame 58 |
- |
|
43
|
|
|
Chromosome 17 open reading frame 67 |
- |
Androgenetic alopecia, Ankylosing spondylitis, Crohn disease, Inflammatory bowel disease, Orofacial cleft, Osteoarthritis, Psoriasis, Retinal detachment, Sclerosing cholangitis, Sleep apnea, Amyotrophic lateral sclerosis, Ulcerative colitis |
44
|
|
|
Chromosome 17 open reading frame 99 |
IL-40, UNQ464 |
|
45
|
|
|
Chromosome 18 open reading frame 32 |
GPIBD25 |
|
46
|
|
|
Chromosome 18 open reading frame 54 |
LAS2 |
|
47
|
|
|
Chromosome 19 open reading frame 12 |
MPAN, NBIA3, NBIA4, SPG43 |
Spastic paraplegia, Breast cancer, Estrogen-receptor negative breast cancer, Global developmental delay, Hallervorden spatz syndrome, Intellectual developmental disorder, Urinary system neoplasms, Metabolic syndrome, Neurodegeneration with brain iron accumulation, Ovarian neoplasms, Ovarian serous carcinoma, Spastic ataxia, Hereditary spastic paraplegia, Diabetes mellitus type 2, Urinary bladder cancer |
48
|
|
|
Chromosome 19 open reading frame 18 |
- |
|
49
|
|
|
Chromosome 19 open reading frame 33 |
H2RSP, IMUP, IMUP-1, IMUP-2 |
|
50
|
|
|
Chromosome 19 open reading frame 38 |
HIDE1 |
|